Murugesh Kandasamy

Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and PharmaceuticsMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease”.

SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late‐onset Alzheimer's disease

Alzheimer s & Dementia Translational Research & Clinical Interventions(2023)10.1002/trc2.12429

N/A

0.385DataRank · unranked

12 citations

Emily R. Mason, Shaoyou Chu, Adrian L. Oblak, June Javens‐Wolfe, Mustapha Moussaif +23 more

STOP‐AD portal: Selecting the optimal pharmaceutical for preclinical drug testing in Alzheimer's disease

Alzheimer s & Dementia(2023)10.1002/alz.13108

N/A

0DataRank · unranked

3 citations

Murugesh Kandasamy, Adrian L. Oblak, Kristen D. Onos, Mike Sasner, Anna K Greenwood +4 more